Food, Drugs, Healthcare, Life Sciences

In Otsuka Pharmaceutical Co. v. Sandoz, Inc., the Federal Circuit upheld the district court’s determination that the claims at issue were neither obvious nor invalid under the doctrine of obviousness-type double patenting based on a "lead compound" approach to the obviousness determinations.

After the Supreme Court decided that the personalized medicine method claims at issue in Mayo Collaborative Services v. Prometheus Laboratories, Inc. did not satisfy the patent eligibility requirements of 35 USC § 101.

GlaxoSmithKline and Genentech have settled a U.S. lawsuit related to Genentech's Cabilly II (US 6,331,415) and Cabilly III (US 7,923,221) patents.

As public-facing representations, inaccurate Notices of Privacy Pracধces ("NPP") can provide a basis for decepধve or unfair trade pracধces or unfair compeধধon claims, including under the FTC Act.

Over the past two decades, genetic engineering, synthetic biology, and bioinformatics have revolutionised plant science. In this Insight, we explore how recent advances in plant biotechnology...

On June 26, 2025, Representatives Chrissy Houlahan (D-PA) and Stephanie Bice (R-OK) announced the formation of the BIOTech Caucus. According to Houlahan's June 26, 2025, press release, the Caucus' mission...

On June 23, HHS Secretary Kennedy and CMS Administrator Dr. Mehmet Oz held a roundtable with health insurance companies to discuss a new pledge to "streamline and improve the prior authorization processes...

On June 25 and 26, the reconstituted Advisory Committee on Immunization Practices (ACIP) convened to discuss updates and recommendations regarding vaccines, particularly focusing on respiratory syncytial virus (RSV)...

The U.S. Food and Drug Administration (FDA) proposed the use of a new, systematic tool to guide how it will rank and prioritize substances in food for post-market safety reviews.

The Supreme Court ruled on June 26 in Medina v. Planned Parenthood that Medicaid enrollees cannot bring private lawsuits against states to enforce their right to choose among willing and qualified providers...

On June 30, 2025, New York State released its long-anticipated Master Plan for Aging (MPA), a 10-year strategic framework designed to improve the way the state supports older adults...

The Senate recently voting 99-1 to remove a 10-year moratorium on state regulation of AI says something about the impact of AI, but also its challenges.